Key Highlights

  • Published calendars place Moderna, Humana and Vistra among the pre-open reporters on Friday, November 6, 2026, with Charter Communications, Enbridge, Brookfield Asset Management, Ubiquiti and Franklin Templeton also listed.
  • One market data page estimates Humana's result at a loss of roughly USD 1.03 per share, set against USD 3.24 earned a year before, and cautions that the number could be wrong.
  • Vistra's expected figure is near USD 2.77 per share, up from USD 1.75, while Moderna's expected loss of roughly USD 1.10 per share is wider than the USD 0.51 loss of a year ago.
  • The S&P 500, which SPDR S&P 500 ETF Trust (NYSEARCA:SPY) tracks, reportedly lost 4.36% to 7,353.73 on November 5, 2026, according to one closing tally, so the reports arrive after a sharp sell-off.

Four Scheduled Reports Land Before the Friday Open

Friday, November 6, 2026 brings a dense run of pre-open earnings. Releases issued before the bell give the market its first read, and later conference calls can change the picture. Published calendars show Moderna, Humana, Vistra and Charter Communications reporting, with Enbridge, Brookfield Asset Management, Ubiquiti and Franklin Templeton also on the list. Charter appeared in only one of the two calendars reviewed, so its timing is less certain. Every item here is a scheduled event, and none had produced results at the time of writing. Each name carries a modest weight in SPDR S&P 500 ETF Trust (NYSEARCA:SPY), so a single report seldom moves the fund by itself.

Consensus Numbers for Humana, Vistra and Moderna

The figures here come from one market data page that cautions its estimates may be inaccurate, so they should be treated as approximate. Humana last reported on July 29, 2026, posting Earnings of USD 7.61 against a USD 6.22 estimate, yet its shares dropped 6.0% that day, a reminder that beating expectations does not guarantee a rally. Humana's result is the widest projected gap in the group, which is why it draws the most attention. Vistra also beat in August. No Charter estimate was located, and no Revenue consensus was found for any of the four companies.

Jobs Data and a Fragile Tape Frame the Day

The October employment report lands the same day, with nonfarm payrolls forecast between 55,000 and 65,000 depending on the account, compared with 29,000 in September, and Unemployment expected at 4.2%. Early futures readings were mixed: Nasdaq-100 contracts were up about 1%, S&P 500 contracts 0.2% to 0.3% higher, and Dow contracts 0.7% to 0.95% lower. Coming after Nasdaq-100 losses that tallies placed between 5.1% and 6.36% on November 5, investors face earnings, jobs and a consumer sentiment reading within one session. Watch Humana's cost trends for medical care, Vistra's power pricing and Moderna's Vaccine Demand for direction.

Where Things Stand

No single report looks likely to dominate, though Humana draws the most attention on the figures available. The move from a USD 3.24 profit a year ago to an expected loss near USD 1.03 makes medical cost commentary the widest swing among the four. Vistra and Moderna each add separate signals. Regarding SPDR S&P 500 ETF Trust (NYSEARCA:SPY), employment data and whatever follows Thursday's decline may matter more than any single company. Next markers are the actual results, management guidance and early trading, which can reverse once conference calls add detail.